Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A New Option to Treat Intermediate Hepatocellular Carcinoma?
BARCELONA — Adding lenvatinib and pembrolizumab to transarterial chemoembolization (TACE) led to a significant improvement in progression-free survival in patients with intermediate-stage hepatocellular carcinoma compared with TACE plus placebo, according to findings from the first interim analysis of the phase…
English